CIK 0001479615 · Non-accelerated filer<br>Smaller reporting company
Silence Therapeutics plc
Sign in to watch- Tickers
- SLN SLNCF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 44-0-20-3457 6900
- Business address
- 12 HAMMERSMITH GROVE, OFFICE 205, LONDON, United Kingdom, W6 7AP
Securities
- SLN American Depository Share Nasdaq
- SLNCF Common stock OTC
- 4 Insider Changes in Ownership
- 8-K Event Regulation FD disclosure
- 8-K Event Shareholder vote results
- 8-K Event Other events
- EFFECT Other Notice of Effectiveness
- 424B5 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 8-K Event Material agreement · Agreement ended · Other events
- S-3 Offering Registration Statement
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations · Regulation FD disclosure
- 4 Insider Changes in Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- UPLOAD Other SEC-generated Letter
Page 2 of 14 · 277 filings